Development of stable affinity columns for antibody purification

• Unité de recherche: INNOSUISSE
• Numéro de projet: 17003.1 PFLS-LS
• Titre du projet anglais: Development of stable affinity columns for antibody purification

Description succincte (Allemand)

Development of stable affinity columns for antibody purification

Description succincte (Anglais)

Development of stable affinity columns for antibody purification

Résumé des résultats (Abstract) (Allemand)

Monoclonal antibodies (MAbs) account for a large share of the rapidly growing biological drugs|market. Whilst the market for such drugs is expected to reach $62.3 billion in 2015, the biggest|obstacle in MAb production ¿ purification, is still suboptimal. Expensive Protein A resins are|used but they can be sensitive to elution and sterilization conditions. In combination with|ChromaCon¿s proprietary technology, this project aims to develop and commercialize a novel,|efficient and cost effective antibody purification process using a novel affinity reagent for|humanized antibodies.

Résumé des résultats (Abstract) (Anglais)

Monoclonal antibodies (MAbs) account for a large share of the rapidly growing biological drugs|market. Whilst the market for such drugs is expected to reach $62.3 billion in 2015, the biggest|obstacle in MAb production ¿ purification, is still suboptimal. Expensive Protein A resins are|used but they can be sensitive to elution and sterilization conditions. In combination with|ChromaCon¿s proprietary technology, this project aims to develop and commercialize a novel,|efficient and cost effective antibody purification process using a novel affinity reagent for|humanized antibodies.